Cagent Vascular, Inc. announced the successful completion of the first-in-human-use (FIH) procedures with the Serranator Sonic intr ...
SANTA CLARA, Calif., Dec. 04, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ...
Medical Device Network on MSN
Cagent Vascular raises $41M for dual-modality IVL platform advancement
Cagent will use the funds to complete a pivotal trial of its Serranator SONIC IVL system and support commercial necessitates ...
Initial FIH procedures launch FastWave's multi-center feasibility study evaluating the safety and performance of its laser-based coronary IVL platform. MINNEAPOLIS, June 3, 2025 /PRNewswire/ -- ...
For decades, doctors have struggled with the same stubborn problem: arteries hardened by calcium are too rigid for standard ...
SANTA CLARA, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ...
SAN FRANCISCO — Two different balloon devices developed for the treatment of calcified coronary lesions were found noninferior to intravascular lithotripsy (IVL) at a lower cost in separate major ...
With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for ...
HACKENSACK, N.J. (CBSNewYork)-- One of the most common heart procedures done in this country is a called a coronary angioplasty. A balloon opens up a heart artery and usually a stent is placed to keep ...
FastWave Medical has added four international patents to its intellectual property portfolio, bringing the company's total to 13 patents worldwide, including nine in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results